Eurofins BioPharma Services Newsletter 34 - February 2023
ARTICLES:
- TruGraf Liver, the first and only gene expression diagnostic that helps optimise immunosuppression treatment for liver transplant patients
- TEM is the ideal complement to in-vitro assays and molecular techniques in determining the microbiological safety of biological products
- Ensuring consumer safety and regulatory compliance for OTC drugs, cosmetic products, and dietary supplements
- Eurofins Discovery helps researchers understand human toxicities related to PFAS
- Celebrating 35 years of Testing for Life – 35 YEARS OF EUROFINS
- Eurofins BioPharma Product Testing offers comprehensive testing services to qualify filters for sterile drug manufacturing
Download the PDF version of pharma newsletter N°34
